Osteoporosis RiskNCT07034131
Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge
A study testing Osteo-Buddy in people with Osteoporosis Risk and Osteoporosis, Postmenopausal, run by SingHealth Polyclinics.
Trial summary
This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women. Read more about this study
- Who is it for?
- Ages 50 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Osteoporosis Risk, Osteoporosis, Postmenopausal
- What is being tested?
- Osteo-Buddy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- No sites listed yet
- Study dates
- Jul 2025to Mar 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 50 and above
- Medium or high Osteoporosis Self-Assessment Tool for Asians (OSTA) score
- Not undertaken Bone Mineral Density (BMD) scan
- Never been treated with anti-osteoporosis medications such as bisphosphonates (e.g. alendronate, risendronate, ibandronate, zolendronate, pamidronate) or denosumab
- Able to read and speak English
- Currently use and own a smartphone where Osteo-Buddy can be used
Who cannot join
- Known terminal illness
- Visual, hearing and/or cognitive impairment or mental illness that renders them unable to provide informed consent
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Improving Both Health in Women With the Use of Osteo-Buddy to Enhance Osteoporosis Knowledge - A Mixed Method Clinical Trial
This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.
Read the detailed description
This study will involve evaluating the preliminary effectiveness and feasibility outcomes of the use of Osteo-Buddy, a Virtual Health Assistant (VHA), in improving the knowledge of osteoporosis in women aged 50 and above.
- Conditions
- Osteoporosis Risk, Osteoporosis, Postmenopausal
- Being tested
- Osteo-Buddy, Usual Care
- Medical subject headings
- Osteoporosis, Postmenopausal
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Osteo-BuddyOther
Osteo-Buddy is a Virtual Health Assistant (VHA) accessible on mobile phones that helps users with:
- Evaluating their risk level of osteoporosis
- Recommending screening and referrals
- Lifestyle interventions through motivation, education and tailored guidance
As a 24/7 VHA, it offers real-time, personalised advice based on user inputs and health data.
Usual CareOther
Access to digitalised educational materials on osteoporosis, titled 'Healthy Bones'
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | use of Osteo-Buddy for 4 weeks Receives: Other: Osteo-Buddy; Other: Usual Care |
| Control | Experimental | usual care - access to digitalised educational materials titled 'Healthy Bones' Receives: Other: Usual Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Osteoporosis Prevention and Awareness Tool (OPAAT) score
- 30-item questionnaire measuring osteoporosis knowledge
- Minimum value = 0, maximum value = 30
- Higher scores indicate a better outcome
Measured: On enrolment and 6-8 weeks post enrolment
System Usability Scale (SUS)
- 10-item questionnaire assessing usability
- Minimum value = 0, maximum value = 100
- Higher scores mean a better outcome
Measured: 6-8 weeks post enrolment
Secondary outcomes (3)
Recruitment rate
Percentage of participants successfully recruited among referred participants
Measured: over the course of recruitment, estimated 3-4 months
Retention rate
Percentage of recruited participants who complete the study (return for 2nd visit and successfully complete 2nd questionnaire)
Measured: 6-8 weeks post-enrolment
Utility rate
Percentage of intervention arm participants who utilise Osteo-Buddy over the 4 weeks
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jun 2025
- Study startJul 2025 (estimated)
- Primary completionMar 2026 (estimated)
- Study completionMar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Osteoporosis RiskStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- SingHealth Polyclinics
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Eunice Lim Shi Min, SingHealth Polyclinics
- Investigators
- Eunice Lim, Principal investigator, SingHealth Polyclinics
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07034131
- Sponsor's protocol ID
- 2025-0064
- Status last verified
- Jun 2025
- First submitted
- 13 Jun 2025
- Last updated
- 1 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: In view of concerns regarding patient confidentaility and data security, IPD will not be shared.
Study at a glance
From the registry record, last updated by the sponsor on 1 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Both Health in Women With the Use of Osteo-Buddy to Enhance Osteoporosis Knowledge - A Mixed Method Clinical Trial
- ClinicalTrials.gov ID
- NCT07034131
- Acronym / sponsor ID
- 2025-0064
- Conditions
- Osteoporosis Risk, Osteoporosis, Postmenopausal
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- SingHealth PolyclinicsUniversity, hospital or other
- Study start
- Jul 2025 (estimated)
- Primary completion
- Mar 2026 (estimated)
- Study completion
- Mar 2026 (estimated)
- First posted
- 24 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.
Detailed description
This study will involve evaluating the preliminary effectiveness and feasibility outcomes of the use of Osteo-Buddy, a Virtual Health Assistant (VHA), in improving the knowledge of osteoporosis in women aged 50 and above.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: Osteo-Buddy, Other: Usual Careuse of Osteo-Buddy for 4 weeks |
| Control | Experimental | Other: Usual Careusual care - access to digitalised educational materials titled 'Healthy Bones' |
Who may qualify
- Ages
- 50 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Age 50 and above
- Medium or high Osteoporosis Self-Assessment Tool for Asians (OSTA) score
- Not undertaken Bone Mineral Density (BMD) scan
- Never been treated with anti-osteoporosis medications such as bisphosphonates (e.g. alendronate, risendronate, ibandronate, zolendronate, pamidronate) or denosumab
- Able to read and speak English
Key exclusion criteria (2 listed)
- Known terminal illness
- Visual, hearing and/or cognitive impairment or mental illness that renders them unable to provide informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Osteo-BuddyOsteo-Buddy is a Virtual Health Assistant (VHA) accessible on mobile phones that helps users with: 1. Evaluating their risk level of osteoporosis 2. Recommending screening and referrals 3. Lifestyle interventions through motivation, education and tailored guidance As a 24/7 VHA, it offers real-time, personalised advice based on user inputs and health data. | Other | Intervention |
| Usual CareAccess to digitalised educational materials on osteoporosis, titled 'Healthy Bones' | Other | Control, Intervention |
Primary outcome
Osteoporosis Prevention and Awareness Tool (OPAAT) score
Time frame: On enrolment and 6-8 weeks post enrolment
* 30-item questionnaire measuring osteoporosis knowledge * Minimum value = 0, maximum value = 30 * Higher scores indicate a better outcome
System Usability Scale (SUS)
Time frame: 6-8 weeks post enrolment
* 10-item questionnaire assessing usability * Minimum value = 0, maximum value = 100 * Higher scores mean a better outcome
3 secondary outcomes
Recruitment rate
Time frame: over the course of recruitment, estimated 3-4 months
Retention rate
Time frame: 6-8 weeks post-enrolment
Utility rate
Time frame: 4 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jul 2025.
- Individual participant dataSharing planned: No. In view of concerns regarding patient confidentaility and data security, IPD will not be shared.
Related trials for Osteoporosis Risk
Not yet recruiting
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE PROGRAM TARGETING BALANCE-POSTURE INTERACTION AND FALL RISK IN OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIAL
Osteoporosis, Risk of Falls
RecruitingPhase 2
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
Healthy, Osteopenia
Not yet recruiting
Evaluation of Dora Care for Supporting Fracture Liaison Services (FLS)
AI (Artificial Intelligence), Osteoporosis
Recruiting
Comparison of Bone Microarchitecture Analysed by HRpQCT and pQCT in Pathologies With Bone Loss and/or Muscle Loss
Osteoporosis Risk, Bone Loss
Active, not recruitingObservational study
Pregnancy and Lactation- Associated Osteoporosis
Osteoporosis and Fracture Risk in Pregnant Women
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Eunice Lim principal investigator
SingHealth Polyclinics
Questions about this trial
What is this clinical trial studying?
A study testing Osteo-Buddy in people with Osteoporosis Risk and Osteoporosis, Postmenopausal, run by SingHealth Polyclinics.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Eunice Lim (+65 6340 7436, eunice.lim.s.m@singhealth.com.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Osteoporosis Prevention and Awareness Tool (OPAAT) score (time frame: On enrolment and 6-8 weeks post enrolment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2025; AzTrials last refreshed its copy on 26 Oct 2026.